Case-control studies to assess vaccine effectiveness? Yes, but not this way [1]

Clinical Infectious Diseases

Volumn 45, Issue 9, 2007, Pages 1240-1241

  Bernaola, Enrique ^a   Herranz, Mercedes ^a   Clerigué, Nuria ^a   Gil, Francisco ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

CASE CONTROL STUDY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; FOLLOW UP; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; LETTER; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; VACCINATION;

CASE-CONTROL STUDIES; HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; SELECTION BIAS;

EID: 35348825495     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522286     Document Type: Letter

References (10)

1. Barricarte A, Castilla J, Gil-Setas A, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study. Clin Infect Dis 2007; 44:1436-41.
2. Grimes DA, Schutlz KF. Bias and causal associations in observational research. Lancet 2002; 359:248-52.
3. Bland JM, Altman DG. Matching. BMJ 1994; 309:1128.
4. Barricarte A, Gil-Setas A, Torroba A, et al. Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000-2005): impact of the conjugate vaccine [in Spanish]. Med Clin (Barc) 2007; 129:41-5.
5. Flannery B, Heffernan RT, Harrison LH, et al. Changes in invasive disease pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 2006; 144:1-9.
6. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by non-vaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784-92.
7. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54:893-7.
8. Kellner JD, Church DL, MacDonald J, et al. Progress in prevention of pneumococcal disease. CMAJ 2005; 173:1149-51.
9. Roche P, Krause V, Cook H, et al. Invasive pneumococcal disease in Australia, 2005. Commun Dis Intell 2007; 31:86-100.
10. Aristegui J, Bernaola E, Pcheville I, et al. Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis 2007; 26:303-10.